Objective: To evaluate Nazilli Tuberculosis Dispensary activities executed between 1st June, 1996- 31st May, 2000 and to compare differences among 12-month-periods.
Design: Retrospective analyses of data.
Settings: People living in the villages under responsibility of Nazilli Tuberculosis Dispensary.
Population: People examined in out-patient clinic as symptomatic cases, for health report or during contact examination, number of mycobacteriological and radiological examinations, and tuberculosis cases detected in each year.
Main Results: Average number of newly diagnosed tuberculosis patient in every 12-month-period was 105. The average rate for new tuberculosis cases finding was 52.5%. Pulmonary tuberculosis was in 74.8% of all tuberculosis cases. The range of smear positive pulmonary tuberculosis cases in all tuberculosis cases differed from 49% to 71% and a decrease in the rate of cases with no sputum smear from 18% to 3% were observed. The average of bacteriological conversion rate at the end of second therapy month was 70.5%. The average of cure rate in new smear positive patients was 82%. According to drug susceptibility test results, 13 of new smear positive cases and 5 of old cases were multi-drug resistant tuberculosis.
Conclusion: Although the treatment success of either new smear positive or old smear positive tuberculosis cases were high, it is necessary to plan strategies for increasing the new case finding rate to 70%, the rate suggested by World Health Organization. The data obtained by this study showed that hopeful results may be achieved by stable staff and team-work in tuberculosis dispensary.
Download full-text PDF |
Source |
---|
Indian J Med Ethics
January 2025
Consultant Gastroenterologist, Kalinga Gastroenterology Foundation, Bajrakabati Road, Cuttack, Odisha, 753007, INDIA.
In 2023, as per the World Health Organization (WHO), India emerged as the country with the highest number of tuberculosis (TB) cases, reporting 2.8 million cases and contributing to 27% of the global TB burden [1]. Worldwide, there were 7.
View Article and Find Full Text PDFOpen Forum Infect Dis
January 2025
Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Background: The global resurgence of disseminated tuberculosis (TB) after the coronavirus disease 2019 pandemic highlights the necessity of understanding host risk factors, especially in adults without human immunodeficiency virus.
Methods: We reviewed TB cases admitted to Shanghai Public Health Clinical Center from 2017 to 2022. We analyzed baseline characteristics and outcomes.
F1000Res
January 2025
Faculty of Medicine and Health Sciences, Division of Epidemiology and Biostatistics, Stellenbosch University Centre for Evidence-Based Health Care, Cape Town, South Africa.
Background: Tuberculosis (TB) is a leading cause of death worldwide with over 90% of reported cases occurring in low- and middle-income countries (LMICs). Pre-treatment loss to follow-up (PTLFU) is a key contributor to TB mortality and infection transmission.
Objectives: We performed a scoping review to map available evidence on interventions to reduce PTLFU in adults with pulmonary TB, identify gaps in existing knowledge, and develop a conceptual framework to guide intervention implementation.
Background: Among occupational hazards in healthcare settings, latent tuberculosis infection (LTBI) ranks as a major concern, particularly threatening healthcare workers (HCWs) in nations grappling with intermediate to high tuberculosis (TB) rates. Our study was conducted in Morocco, a country characterized by widespread Bacillus Calmette-Guérin (BCG) vaccination and a moderate TB burden of 93 cases per 100,000 inhabitants in 2022. We examined both the prevalence of LTBI among Moroccan HCWs and its various risk factors.
View Article and Find Full Text PDFNarra J
December 2024
Department of Clinical Pathology, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia.
Successfully treating tuberculosis (TB) could significantly help reduce its spread. The aim of this study was to identify factors associated with successful TB treatment. A retrospective study was conducted in West Nusa Tenggara, Indonesia, using data from the National TB Information System (SITB) covering patients from January 1 to December 31, 2022.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!